Susan Lynch

Susan Lynch, PhD, is a Professor of Medicine at the University of California, San Francisco (UCSF) School of Medicine. Her research focuses on the human microbiome's role in immune regulation and chronic inflammatory diseases, particularly asthma, allergy, and inflammatory bowel disease. She leads translational studies linking early-life microbial exposures to childhood disease trajectories and has pioneered microbial therapeutic development.

Education:

• PhD in Microbiology, University College Dublin (2000)
• BS in Microbiology/Biostatistics, University College Dublin (1995)
• Diversity, Equity, and Inclusion Champion Training, University of California (2020)

Research Interests:

Lynch's work integrates microbiome analysis with clinical outcomes, emphasizing:

• Microbiome-immunity interactions in asthma/allergy prevention
• Gut-lung axis mechanisms in respiratory disease
• Microbial therapeutics for immune modulation
• Preterm birth prediction via microbiome signatures

Key Achievements:

• Fellow of the American Academy of Microbiology
• Founder of Siolta Therapeutics (microbiome-based allergy prevention)
• Recipient of major grants from NIH, including the ECHO Program and I AM GOLD Study
• Over 200 peer-reviewed publications and multiple patents

Labs/Teams:

Lynch directs the Benioff Center for Microbiome Medicine at UCSF, collaborating with global networks like the Living Therapeutics Initiative. Her team uses omics technologies and clinical trials to advance microbiome-driven therapies.